OMORON collaborate with Indian healthcare startup Leading healthcare monitoring brand, OMRON Healthcare India, has partnered with PhableCare. This partnership aims to make use of artificial intelligence (AI). As a result, […]
Leading healthcare monitoring brand, OMRON Healthcare India, has partnered with PhableCare. This partnership aims to make use of artificial intelligence (AI). As a result, AI will enable healthcare management players to provide a one-stop remote hypertension management services at home.
Thanks to this partnership, they can bring technology and healthcare together. Hypertensive patients will be able to enjoy all kinds of services right from diagnosis to monitoring to treatment from home. Thus, AI and machine learning (ML) will enhance doctors’ expertise, patients’ data and health devices. In fact, Masanori Matsubara, MD, OMRON Healthcare India mentioned in the following way.
“Autonomous & AI based healthcare becomes the new normal now. OMRON has been contributing to keep track of heart health by providing high quality products. Millions of patients enjoy monitoring their condition efficiently under the supervision of doctors from home, thanks to our partnership. The patients will get access to an accurate monitoring device, proper diagnosis, prescription, real time tracking and monitoring. What’s more, they will be able to enjoy efficient drug delivery & risk analysis.”
According to its official page, OMRON is a global leader in the field of automation. OMRON covers several business fields including industrial automation, electronic components and healthcare. At present, OMRON provides products and services in around 120 countries and regions.
When it comes to hypertension, nearly 1 billion people around the world are estimated to suffer the disease. Hypertension usually has no symptoms, but it is a major cause of cerebrovascular and cardiovascular diseases such as stroke and heart attack. Every year, the number of patients with these diseases is gradually growing.
Even when these life-threatening diseases do not result in death, patients can often become bedridden or suffer from speech impairment. This causes a marked drop in patients’ quality of life (QOL). To get matters worse, these outcomes increase burdens on families who care for them.
OMRON seeks to help all people around the world to improve and maintain their QOL and lengthen their healthy lifespan. To this purpose, OMRON is committed to creating blood pressure monitors as well as other innovative products and services.
PhableCare has clear mission and vison. Its mission is to make daily care accessible for patients with lifestyle diseases and build India’s first complete care ecosystem. Its vision is to serve the next billion Indians and help them manage their chronic diseases better. Since healthcare is becoming personal, predictive, and preventative, and they want to be at the forefront of this change.
We can find several key words in the healthcare industry among this announcement: Remote and AI.
First of all, the pandemic makes us find the reality that remote operation is very important in the healthcare industry. Of course, this trend is not new and many companies proceeded with it. However, due to the pandemic, most of us experienced the necessity to take care of others and keep social distance at the same time. In this sense, not only remote diagnosis but remote surgery will be more popular in the future.
Second, AI will be able to improve or change our treatment. This is because AI can do what human beings cannot do. For example, the technology can find the pattern among tons of the data. Therefore, AI will be useful for hypertension care as well as other critical diseases including cancer.
When we think of the negative side of these new technologies, probably regulations, rules and laws cannot cover them. The healthcare industry is directly related to our life so that regulations and rules are very important. However, they may prevent us from realizing innovations at the same time. Therefore, balance between technologies and regulations is critical. In India, there are fewer rules relating to healthcare compared to other advanced countries. Thus, this partnership can bring the next stage about hypertension care.
